Almus F E, Rao L V, Fleck R A, Rapaport S I
Department of Medicine, University of California, San Diego, La Jolla 92093.
Blood. 1990 Jul 15;76(2):354-60.
An umbilical vein model was designed in which washed vein segments are filled with a reaction mixture containing factor VIIa, Ca(+)+, and a substrate, either 3H-factor IX or 3H-factor X. The vein wall provides the tissue factor (TF) for factor VIIa/TF complexes that activate the substrates as measured by activation peptide release. The model was developed to study TF induced on venous endothelium in situ. However, unlike previous studies with TF expressed on cultured umbilical vein endothelial cells, factors IX and X were activated without first having to expose the vein wall to a perturbing stimulus. Histologic studies revealed that washing the vein and mixing the reaction mixture before subsampling had disrupted the endothelium. Immunostaining with anti-TF antibodies revealed no staining of endothelium but intense staining in extensions of Wharton's jelly penetrating fenestrations of the muscularis media of the vein. Thus, the model provided data on factor VIIa/TF formed, not on endothelium, but within the mucoid connective tissue of Wharton's jelly. It is known that factor VIIa/TF formed with TF in suspension or with TF expressed on the surface of cultured cells activates factor X more rapidly than factor IX. In contrast, in the umbilical vein model, when each substrate was present in an 88 nmol/L concentration, factors IX and X were activated at equivalent rates (mean activation rate for factor IX, 18.8 +/- 3.6 nmol/L/h; for factor X, 17.8 +/- 2.9 nmol/L/h; n = 9 paired vein segments). These data strengthen the evidence that factor VIIa/TF activation of factor IX represents a key initial reaction of coagulation in tissues. These results also show that data obtained with factor VIIa/TF complexes formed on the surface of cultured cells need not hold for factor VIIa/TF complexes formed in extracellular matrix.
设计了一种脐静脉模型,将洗净的静脉段填充含有因子VIIa、钙离子和底物(3H标记的因子IX或3H标记的因子X)的反应混合物。静脉壁为因子VIIa/组织因子(TF)复合物提供组织因子,通过激活肽释放来测量,该复合物可激活底物。开发该模型是为了研究原位静脉内皮细胞上诱导产生的组织因子。然而,与之前在培养的脐静脉内皮细胞上表达组织因子的研究不同,因子IX和因子X的激活无需先将静脉壁暴露于干扰刺激下。组织学研究显示,在进行子样本采集之前清洗静脉并混合反应混合物会破坏内皮细胞。用抗组织因子抗体进行免疫染色显示,内皮细胞无染色,但在华通氏胶延伸至静脉肌层开窗处有强烈染色。因此,该模型提供的是关于在华通氏胶的黏液结缔组织内形成的因子VIIa/组织因子的数据,而非关于内皮细胞的数据。已知在悬浮液中与组织因子形成的或在培养细胞表面表达的组织因子形成的因子VIIa/组织因子,激活因子X的速度比激活因子IX更快。相比之下,在脐静脉模型中,当每种底物浓度为88 nmol/L时,因子IX和因子X以相同的速率被激活(因子IX的平均激活速率为18.8±3.6 nmol/L/小时;因子X为17.8±2.9 nmol/L/小时;n = 9对静脉段)。这些数据进一步证明,因子VIIa/组织因子对因子IX的激活是组织中凝血的关键初始反应。这些结果还表明,在培养细胞表面形成的因子VIIa/组织因子复合物所获得的数据不一定适用于在细胞外基质中形成的因子VIIa/组织因子复合物。